Intelligent Bio Solutions Reports 46% Q3 Revenue Growth, 50.5% Gross Margin, and $6.86M Cash Balance
INBS sits 82% above its 52-week low of $2.27 on elevated volume (4.8× avg).
Summary
Intelligent Bio Solutions reported strong Q3 fiscal 2026 results with 46% revenue growth and expanded gross margins, alongside a significant increase in cash to $6.86 million, providing a crucial financial runway.
Key Events · Earnings and Guidance · INBS
-
Strong Q3 Revenue Growth
Total revenue increased 46% year-over-year to $1.06 million for the fiscal third quarter ended March 31, 2026, building on consistent growth.
-
Expanded Gross Profit Margin
Gross profit margin reached 50.5% in Q3, up from 46.8% in the prior year, driven by operational efficiencies and increased sales volumes.
-
Significant Cash Position
Cash and cash equivalents surged to $6.86 million as of March 31, 2026, compared to $740,371 at December 31, 2025, following a $14.67 million capital raise.
-
Recurring Revenue Model Traction
Cartridge sales, representing the recurring revenue component, grew 59% year-over-year and accounted for 66% of Q3 revenue, confirming the success of the razor-razorblade business model.
Analysis · INBS · Industrial Applications And Services
This 8-K provides detailed financial results for the fiscal third quarter, following yesterday's 10-Q which disclosed a going concern warning. The report highlights strong operational performance with 46% year-over-year revenue growth and an expanded gross profit margin of 50.5%. Crucially, the company's cash and cash equivalents surged to $6.86 million, largely due to a $14.67 million capital raise over the nine-month period. This significant cash infusion, representing a substantial portion of the company's market capitalization, provides a critical runway and directly addresses immediate liquidity concerns, which is highly important given the previously disclosed going concern.
How filings like this one have moved
In the 30 days to Oct 26, 2026, 36.2% of the 898 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.75%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, INBS was trading at $4.14 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $8M. The 52-week trading range was $2.27 to $24.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.